Product Pipeline

Reviva is developing a portfolio of internally discovered next generation innovative therapies using integrated chemical genomic driven approaches and proprietary chemistries for clinically proven targets. Reviva has multiple products in pipeline at various stages of development for chronic conditions in large therapeutic areas and gained a substantial patent position in the US and Worldwide.


PROGRAMS RESEARCH PRECLINICAL PHASE 1 PHASE 2 PHASE 3

RP5063

Schizophrenia
Bipolar Disorder
Depression MDD
Alzheimer’s
Psychosis-BPSD
Parkinson’s Psychosis
ADHD/ADD
PAH (RP5063)
Depression TRD
Obesity
Insomnia
TOP